Magnus Wijkman

1.1k total citations
39 papers, 697 citations indexed

About

Magnus Wijkman is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Magnus Wijkman has authored 39 papers receiving a total of 697 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cardiology and Cardiovascular Medicine, 18 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Surgery. Recurrent topics in Magnus Wijkman's work include Blood Pressure and Hypertension Studies (16 papers), Cardiovascular Health and Disease Prevention (13 papers) and Diabetes Treatment and Management (10 papers). Magnus Wijkman is often cited by papers focused on Blood Pressure and Hypertension Studies (16 papers), Cardiovascular Health and Disease Prevention (13 papers) and Diabetes Treatment and Management (10 papers). Magnus Wijkman collaborates with scholars based in Sweden, United States and Germany. Magnus Wijkman's co-authors include Fredrik H. Nyström, Carl Johan Östgren, Toste Länne, Jan Engvall, Tom Lindström, Marcus Lind, Scott D. Solomon, Irl B. Hirsch, Sofia Dahlqvist and Jarl Hellman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and Diabetes Care.

In The Last Decade

Magnus Wijkman

35 papers receiving 689 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Magnus Wijkman Sweden	16	409	297	187	79	60	39	697
Noriko Kikuchi Japan	11	752 1.8×	142 0.5×	215 1.1×	65 0.8×	43 0.7×	39	942
Margaret Band United Kingdom	12	261 0.6×	455 1.5×	217 1.2×	192 2.4×	47 0.8×	23	860
Joseph A. Diamond United States	15	573 1.4×	124 0.4×	111 0.6×	24 0.3×	57 0.9×	50	773
Elisabeth J. Balkestein Netherlands	8	750 1.8×	133 0.4×	126 0.7×	22 0.3×	156 2.6×	8	882
Angela Price United States	9	207 0.5×	116 0.4×	161 0.9×	18 0.2×	33 0.6×	15	430
Connie E. McCoy United States	9	451 1.1×	167 0.6×	79 0.4×	15 0.2×	39 0.7×	13	761
A. C. Pessina Italy	17	390 1.0×	443 1.5×	384 2.1×	19 0.2×	77 1.3×	39	1.0k
Katarzyna Stolarz Poland	15	346 0.8×	148 0.5×	65 0.3×	44 0.6×	26 0.4×	27	510
Simran K. Bhandari United States	10	300 0.7×	156 0.5×	61 0.3×	26 0.3×	44 0.7×	18	537
Poul Ebbe Nielsen Denmark	11	318 0.8×	135 0.5×	184 1.0×	35 0.4×	46 0.8×	32	622

Countries citing papers authored by Magnus Wijkman

Since Specialization

Citations

This map shows the geographic impact of Magnus Wijkman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magnus Wijkman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magnus Wijkman more than expected).

Fields of papers citing papers by Magnus Wijkman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magnus Wijkman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magnus Wijkman. The network helps show where Magnus Wijkman may publish in the future.

Co-authorship network of co-authors of Magnus Wijkman

This figure shows the co-authorship network connecting the top 25 collaborators of Magnus Wijkman. A scholar is included among the top collaborators of Magnus Wijkman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magnus Wijkman. Magnus Wijkman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Frey, Caroline F., et al.. (2025). Self-Measured Home Orthostatic Hypo- and Hypertension—Prevalence and Associations With Atherosclerosis and Arterial Stiffness. American Journal of Hypertension. 39(3). 372–381.

Carlhäll, Carl‐Johan, Pontus Henriksson, Stergios Kechagias, et al.. (2025). Clinically available predictors of obstructive sleep apnoea requiring treatment in type 2 diabetes patients in primary care. Scientific Reports. 15(1). 8710–8710.

Wijkman, Magnus, et al.. (2025). Prevalence of abnormal thyroid hormone levels in acute new-onset atrial fibrillation. Frontiers in Cardiovascular Medicine. 11. 1518297–1518297.

Lassen, Mats Christian Højbjerg, John W. Ostrominski, Brian Claggett, et al.. (2025). ALDOSTERONE DYSREGULATION AND RISK OF CARDIOVASCULAR OUTCOMES:THE ATHEROSCLEROSIS RISK IN COMMUNITIES STUDY. Journal of the American College of Cardiology. 85(12). 665–665.

Imberg, Henrik, Irl B. Hirsch, Erik Schwarcz, et al.. (2024). Discordance between mean glucose and time in range in relation to HbA1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials. Diabetologia. 67(8). 1517–1526. 8 indexed citations

Polonsky, William H., Henrik Imberg, Jarl Hellman, et al.. (2023). Treatment Satisfaction and Well-Being With Continuous Glucose Monitoring in People With Type 1 Diabetes: An Analysis Based on the GOLD Randomized Trial. Journal of Diabetes Science and Technology. 19(1). 143–152. 2 indexed citations

Brown, Jenifer M., Magnus Wijkman, Brian Claggett, et al.. (2022). Cardiac Structure and Function Across the Spectrum of Aldosteronism: the Atherosclerosis Risk in Communities Study. Hypertension. 79(9). 1984–1993. 33 indexed citations

Wijkman, Magnus, Johnny Ludvigsson, Per Ekman, et al.. (2022). Risk factors, mortality trends, and cardiovascular diseases in people with Type 1 diabetes and controls in Sweden: An observational cohort study. The Lancet Regional Health - Europe. 21. 100469–100469. 9 indexed citations

Malachias, Marcus Vinícius Bolívar, Magnus Wijkman, & Marcello Casaccia Bertoluci. (2022). NT-proBNP as a predictor of death and cardiovascular events in patients with type 2 diabetes. Diabetology & Metabolic Syndrome. 14(1). 64–64. 19 indexed citations

10.

Wijkman, Magnus, Marcus Vinícius Bolívar Malachias, Brian Claggett, et al.. (2021). Resistance to antihypertensive treatment and long‐term risk: The Atherosclerosis Risk in Communities study. Journal of Clinical Hypertension. 23(10). 1887–1896. 7 indexed citations

11.

Wijkman, Magnus, Brian Claggett, Marc A. Pfeffer, et al.. (2021). NT-proBNP versus routine clinical risk factors as a predictor of cardiovascular events or death in people with dysglycemia – A brief report from the ORIGIN trial. Journal of Diabetes and its Complications. 35(7). 107928–107928. 3 indexed citations

12.

Jackson, Alice M., Pardeep S. Jhund, Inder S. Anand, et al.. (2021). Sacubitril–valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction. European Heart Journal. 42(36). 3741–3752. 93 indexed citations

13.

Imberg, Henrik, Magnus Wijkman, Irl B. Hirsch, et al.. (2021). Effect of liraglutide on markers of insulin production in persons with type 2 diabetes treated with multiple daily insulin injections. Journal of Diabetes and its Complications. 36(3). 108110–108110. 2 indexed citations

14.

Östgren, Carl Johan, et al.. (2021). Relationships between cardiovascular risk factors and white-coat hypertension diagnosed by home blood pressure recordings in a middle-aged population. Journal of Hypertension. 39(10). 2009–2014. 16 indexed citations

15.

Blomstrand, Peter, Peter Sjöblom, Mats Nilsson, et al.. (2018). Overweight and obesity impair left ventricular systolic function as measured by left ventricular ejection fraction and global longitudinal strain. Cardiovascular Diabetology. 17(1). 113–113. 65 indexed citations

16.

Wijkman, Magnus, Sofia Dahlqvist, Irl B. Hirsch, et al.. (2018). Predictors and correlates of systolic blood pressure reduction with liraglutide treatment in patients with type 2 diabetes. Journal of Clinical Hypertension. 21(1). 105–115. 14 indexed citations

17.

Sandberg, Keisha R., et al.. (2018). AN EXAGGERATED BLOOD PRESSURE RESPONSE TO EXERCISE IS COMMON IN THE SUBACUTE PHASE AFTER STROKE, BUT IS NOT AFFECTED BY RANDOMIZATION TO 12 WEEKS OF INTENSIVE AEROBIC EXERCISE. Journal of Hypertension. 36(Supplement 1). e91–e92. 1 indexed citations

18.

Guldbrand, Hans, Toste Länne, Mats Fredrikson, et al.. (2015). A prospective observational study of all-cause mortality in relation to serum 25-OH vitamin D3 and parathyroid hormone levels in patients with type 2 diabetes. Diabetology & Metabolic Syndrome. 7(1). 53–53. 17 indexed citations

19.

Spångéus, Anna, Magnus Wijkman, Torbjörn Lindström, et al.. (2013). Toe brachial index in middle aged patients with diabetes mellitus type 2: Not just a peripheral issue. Diabetes Research and Clinical Practice. 100(2). 195–202. 21 indexed citations

20.

Wijkman, Magnus, Ann-Britt Wiréhn, Toste Länne, et al.. (2011). Circadian blood pressure variation in patients with type 2 diabetes – relationship to macro- and microvascular subclinical organ damage. Primary care diabetes. 5(3). 167–173. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact